In this study, we observed that the expression of SOX2, but not OCT4 and NANOG, correlates with poor histological differentiation of endometrial tumors, associates with lymph node metastasis, and predicts a poor survival in patients. This evidence concerns the gene POU5F1 and endometrium neoplasm.